TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Aurena Laboratories Holding AB
Closing information (x1000 NOK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 208,291 | 189,075 | 173,406 |
Financial expenses | 1,561 | 922 | 655 |
Earnings before taxes | 13,031 | 9,926 | 9,423 |
EBITDA | 19,557 | 16,078 | 13,945 |
Total assets | 186,709 | 166,883 | 158,385 |
Current assets | 85,942 | 69,097 | 65,878 |
Current liabilities | 50,432 | 31,363 | 29,448 |
Equity capital | 98,471 | 92,859 | 92,652 |
- share capital | 473 | 488 | 524 |
Employees (average) | 76 | 76 | 74 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 52.7% | 55.6% | 58.5% |
Turnover per employee | 2,741 | 2,488 | 2,343 |
Profit as a percentage of turnover | 6.3% | 5.2% | 5.4% |
Return on assets (ROA) | 7.8% | 6.5% | 6.4% |
Current ratio | 170.4% | 220.3% | 223.7% |
Return on equity (ROE) | 13.2% | 10.7% | 10.2% |
Change turnover | 24,898 | 27,650 | -50,830 |
Change turnover % | 14% | 17% | -23% |
Chg. No. of employees | 0 | 2 | 1 |
Chg. No. of employees % | 0% | 3% | 1% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.